FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155996137> ?p ?o ?g. }

• W2155996137 abstract "ADHD guidelines in the UK suggest that children and adults who respond to pharmacological treatment should continue for as long as remains clinically effective, subject to regular review. To what extent patients persist with treatment from childhood and adolescence into adulthood is not clear. This study aims to describe, in UK primary care, the persistence of pharmacological treatment for patients with ADHD who started treatment aged 6–17 years and to estimate the percentage of patients who continued treatment from childhood and adolescence into adulthood. The Health Improvement Network (THIN) database was used to identify patients with ADHD who received their first prescription for methylphenidate/ dexamfetamine/atomoxetine, aged 6–17 years. Patients were monitored until their ‘censored date’ (the earliest of the following dates: date the last prescription coded in the database ended, end of the study period (31st December 2008), date at which they transferred out of their practice, date of death, the last date the practice contributed data to the database). Persistence of treatment into adulthood was estimated using Kaplan Meier analysis. 610 patients had follow-up data into adulthood. 213 patients (93.4% male) started treatment between 6–12 years; median treatment duration 5.9 years. 131 (61.5%) stopped before 18 years, 82 (38.5%) were still on treatment age ≥18 years. 397 patients (86.4% male) started treatment between 13–17 years; median treatment duration was 1.6 years. 227 (57.2%) stopped before 18 years, 170 (42.8%) were still on treatment age ≥18 years. The number of females in both age categories was too small to formally test for differences between genders in persistence of treatment. Persistence of treatment into adulthood is lower (~40%) compared with published rates of persistence of the condition (~65% when symptomatic definition of remission used). Due to the limited number of patients with data past 18 years, it is important that ongoing monitoring of prescribing into later adulthood is undertaken, particularly to observe the effects of recommendations in new guidelines." @default.
• W2155996137 created "2016-06-24" @default.
• W2155996137 creator A5015721926 @default.
• W2155996137 creator A5017195801 @default.
• W2155996137 creator A5055496519 @default.
• W2155996137 creator A5056372208 @default.
• W2155996137 creator A5063549953 @default.
• W2155996137 creator A5079729727 @default.
• W2155996137 date "2012-12-01" @default.
• W2155996137 modified "2023-10-18" @default.
• W2155996137 title "Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence" @default.
• W2155996137 cites W1905611583 @default.
• W2155996137 cites W1970966565 @default.
• W2155996137 cites W1979698089 @default.
• W2155996137 cites W1991445431 @default.
• W2155996137 cites W2006463161 @default.
• W2155996137 cites W2014193692 @default.
• W2155996137 cites W2016511885 @default.
• W2155996137 cites W2031947904 @default.
• W2155996137 cites W2047798740 @default.
• W2155996137 cites W2052904414 @default.
• W2155996137 cites W2058562698 @default.
• W2155996137 cites W2063518057 @default.
• W2155996137 cites W2111135575 @default.
• W2155996137 cites W2114602088 @default.
• W2155996137 cites W2117104588 @default.
• W2155996137 cites W2121519528 @default.
• W2155996137 cites W2125393606 @default.
• W2155996137 cites W2126271209 @default.
• W2155996137 cites W2128984524 @default.
• W2155996137 cites W2130443119 @default.
• W2155996137 cites W2134951059 @default.
• W2155996137 cites W2137706707 @default.
• W2155996137 cites W2145525277 @default.
• W2155996137 cites W2145683797 @default.
• W2155996137 cites W2151431105 @default.
• W2155996137 cites W2151707887 @default.
• W2155996137 cites W2518157807 @default.
• W2155996137 cites W2601578636 @default.
• W2155996137 cites W4236486344 @default.
• W2155996137 doi "https://doi.org/10.1186/1471-244x-12-219" @default.
• W2155996137 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3570395" @default.
• W2155996137 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23216881" @default.
• W2155996137 hasPublicationYear "2012" @default.
• W2155996137 type Work @default.
• W2155996137 sameAs 2155996137 @default.
• W2155996137 citedByCount "32" @default.
• W2155996137 countsByYear W21559961372013 @default.
• W2155996137 countsByYear W21559961372014 @default.
• W2155996137 countsByYear W21559961372015 @default.
• W2155996137 countsByYear W21559961372016 @default.
• W2155996137 countsByYear W21559961372017 @default.
• W2155996137 countsByYear W21559961372018 @default.
• W2155996137 countsByYear W21559961372019 @default.
• W2155996137 countsByYear W21559961372020 @default.
• W2155996137 countsByYear W21559961372021 @default.
• W2155996137 crossrefType "journal-article" @default.
• W2155996137 hasAuthorship W2155996137A5015721926 @default.
• W2155996137 hasAuthorship W2155996137A5017195801 @default.
• W2155996137 hasAuthorship W2155996137A5055496519 @default.
• W2155996137 hasAuthorship W2155996137A5056372208 @default.
• W2155996137 hasAuthorship W2155996137A5063549953 @default.
• W2155996137 hasAuthorship W2155996137A5079729727 @default.
• W2155996137 hasBestOaLocation W21559961371 @default.
• W2155996137 hasConcept C118552586 @default.
• W2155996137 hasConcept C126322002 @default.
• W2155996137 hasConcept C127413603 @default.
• W2155996137 hasConcept C187212893 @default.
• W2155996137 hasConcept C187320778 @default.
• W2155996137 hasConcept C205545832 @default.
• W2155996137 hasConcept C2426938 @default.
• W2155996137 hasConcept C2777112843 @default.
• W2155996137 hasConcept C2778781522 @default.
• W2155996137 hasConcept C2780783007 @default.
• W2155996137 hasConcept C2781009140 @default.
• W2155996137 hasConcept C71924100 @default.
• W2155996137 hasConcept C98274493 @default.
• W2155996137 hasConceptScore W2155996137C118552586 @default.
• W2155996137 hasConceptScore W2155996137C126322002 @default.
• W2155996137 hasConceptScore W2155996137C127413603 @default.
• W2155996137 hasConceptScore W2155996137C187212893 @default.
• W2155996137 hasConceptScore W2155996137C187320778 @default.
• W2155996137 hasConceptScore W2155996137C205545832 @default.
• W2155996137 hasConceptScore W2155996137C2426938 @default.
• W2155996137 hasConceptScore W2155996137C2777112843 @default.
• W2155996137 hasConceptScore W2155996137C2778781522 @default.
• W2155996137 hasConceptScore W2155996137C2780783007 @default.
• W2155996137 hasConceptScore W2155996137C2781009140 @default.
• W2155996137 hasConceptScore W2155996137C71924100 @default.
• W2155996137 hasConceptScore W2155996137C98274493 @default.
• W2155996137 hasIssue "1" @default.
• W2155996137 hasLocation W21559961371 @default.
• W2155996137 hasLocation W21559961372 @default.
• W2155996137 hasLocation W21559961373 @default.
• W2155996137 hasLocation W21559961374 @default.
• W2155996137 hasLocation W21559961375 @default.
• W2155996137 hasLocation W21559961376 @default.
• W2155996137 hasLocation W21559961377 @default.
• W2155996137 hasLocation W21559961378 @default.
• W2155996137 hasOpenAccess W2155996137 @default.

• next